Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
ID: 354612Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $275K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354612

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DC-24-008.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for early-stage dissemination and implementation research in communication disorders through the R21 grant mechanism (RFA-DC-24-008). This initiative invites innovative projects that focus on integrating evidence-based practices into clinical settings, particularly addressing barriers to adoption in areas such as hearing, balance, taste, smell, voice, speech, and language. Eligible applicants include a diverse range of institutions, with funding available up to $275,000 over a two-year period, and applications are due by October 12, 2024. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DC-24-008.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-DC-24-008-Full-Announcement.html
    RFA-DC-24-008.html
    The Department of Health and Human Services is issuing a funding opportunity through the National Institutes of Health (NIH) aimed at advancing early-stage dissemination and implementation (D&I) research in areas related to communication disorders, such as hearing and language. This new R21 grant (RFA-DC-24-008) invites innovative projects that explore strategies for integrating evidence-based innovations into clinical practice, addressing the barriers to adoption. Eligible applicants are diverse institutions, including higher education, non-profits, and for-profits, with a budget of up to $275,000 over a two-year period. Key components of proposals must include the integration of a D&I process model and other essential D&I research elements, intending to build a foundation for subsequent research. Applications are due by October 12, 2024, with an anticipated review process and award cycle anticipated to begin in March 2025. This funding opportunity aligns with NIH's commitment to transforming research into practice to improve health outcomes, particularly for underserved populations. All applications must adhere strictly to specified guidelines, and a letter of intent is encouraged to aid review preparation.
    Similar Opportunities
    NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity for low-risk clinical trials in communication disorders under Funding Opportunity Number PAR-24-051. This initiative aims to support investigator-initiated projects that develop effective interventions in areas such as hearing, speech, and language, specifically targeting low-risk clinical trials that do not require FDA oversight and adhere to budget limits of under $500,000 in direct costs per year. The funding is particularly significant for enhancing research in communication disorders, ultimately improving public health outcomes through scientifically validated interventions. Interested applicants can submit proposals starting January 5, 2024, with the opportunity closing on January 8, 2028; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering research grants aimed at translating basic research findings into clinical practice, specifically for communication disorders. This funding opportunity encourages collaborations between basic scientists and clinicians to develop practical applications that address hearing, balance, smell, taste, voice, and language disorders, with a focus on milestone-driven proposals that demonstrate a clear connection to clinical conditions and impactful outcomes. The grants, limited to a maximum of $500,000 in direct costs annually, are expected to support 2-3 awards in FY25, with applications due by October 12, 2027. Interested applicants can find more information and submit their proposals through Grants.gov, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD," aimed at stimulating research related to HIV/AIDS and communication disorders. This initiative encourages applications that address high-priority research areas defined by the NIH Office of AIDS Research, focusing on the impact of HIV on hearing, balance, taste, smell, voice, speech, and language, with a budget limit of $275,000 for a two-year project period. Eligible applicants include a diverse range of institutions and organizations, and only low-risk clinical trials that do not require FDA oversight will be supported. Interested parties can find more information and application details at the NIH grants website, with deadlines for submissions ranging from May 2025 to January 2028.
    NIDCD Research Opportunities for New Investigators to Promote Workforce Development (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Deafness and Other Communication Disorders (NIDCD) to support R01 grant applications aimed at promoting workforce development among Early Stage and New Investigators in the field of communication disorders. This initiative encourages applications from individuals from diverse backgrounds, particularly those underrepresented in health-related sciences, and allows for innovative research projects without the necessity of preliminary data, provided they demonstrate feasibility. Applicants can request up to $500,000 in direct costs per year, with a total funding commitment of approximately $2.1 million planned for fiscal years 2026 and 2027 to support around 7-8 meritorious projects. Key application dates begin on January 6, 2025, with a closing date of October 6, 2026; for further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDCD Early Career Research (ECR) Award (R21 Clinical Trial Optional) to support novice researchers in establishing independent careers in biomedical and behavioral sciences, specifically in areas related to hearing, balance, smell, taste, voice, speech, or language. This grant mechanism allows for various research projects, including secondary data analysis and translational research, but cannot be utilized for thesis or dissertation work. The award aims to generate preliminary data to support future R01 applications, with a total funding of up to $375,000 over three years, and applications are due beginning January 19, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-120.html.
    Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)," aimed at supporting studies that address barriers to the adoption and sustainability of evidence-based health interventions, particularly in underserved communities. The initiative encourages research that promotes equitable access to effective practices and explores methods for discontinuing ineffective or harmful interventions, emphasizing the importance of contextual factors and multidisciplinary collaboration. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with a maximum funding amount of $275,000 and a project period of up to two years. Interested parties can find more information and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with applications due by May 7, 2025.
    NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering a funding opportunity titled "NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)." This initiative aims to support cooperative agreements for clinical trials that require FDA oversight, are intended to establish efficacy, or present higher risks to participants, with a budget exceeding $700,000. The funding is crucial for advancing clinical practices in treating communication disorders, emphasizing the inclusion of diverse populations in recruitment and retention strategies. Interested applicants, including various educational and nonprofit organizations, must submit their applications by January 27, 2024, and can find more information at NIH Grants.
    NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDCD Early Career Research (ECR) Award (R21 Clinical Trial Optional) to support emerging researchers in establishing independent careers in biomedical and behavioral research related to hearing, balance, smell, taste, voice, speech, or language. This grant allows for various project types, including secondary data analysis, small research initiatives, and the development of research methodologies or technologies, with the goal of generating preliminary data for future R01 applications. Eligible applicants include a diverse range of institutions, particularly those serving underrepresented groups, and may request up to $375,000 in direct costs over a three-year period. Applications are due by February 17, 2027, and interested parties can find more information and submission guidelines at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Deafness and Other Communication Disorders (NIDCD) for cooperative agreements aimed at supporting clinical trials in communication disorders. Applicants are required to propose a single clinical trial that may necessitate FDA oversight, demonstrate efficacy, or involve higher risks, with an emphasis on substantial interaction with NIDCD staff and comprehensive protections for human subjects. This initiative is crucial for advancing research and establishing effective treatments for conditions related to hearing, balance, taste, smell, voice, speech, and language. Interested applicants can access further details and guidelines through the announcement available at NIH Grants, with a budget that may exceed $700,000 in specific circumstances and a closing date for applications set for October 18, 2027.
    Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)" aimed at supporting studies that identify, develop, and test strategies to overcome barriers to the adoption and sustainability of evidence-based health interventions. The initiative encourages applications that promote equitable dissemination among underrepresented communities and address the de-implementation of ineffective practices, with a focus on innovative strategies for embedding these approaches into clinical and community settings. Interested applicants, including various educational institutions and community organizations, can submit proposals through the R21 Exploratory/Developmental Research Grant mechanism, with applications due by January 7, 2028. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-143.html.